DR is defined as an eye disorder that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye which acts as a film for the formation of an image. Long-term diabetes affects the retina as a high blood glucose level can deteriorate and damage the tiny blood vessels in the retina. DR is broadly classified into either non-proliferative DR or proliferative retinopathy. Treatment for DR is dependent on the stage of the disease and is directed at trying to slow or stop the progression of the disease. At present, three types of treatment exist for DR: laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy. Analysts forecast the Global Diabetic Retinopathy market will grow at a CAGR of 6.8 percent over the period 2013-2018.
The acceptability of DR drugs is expected to rise because of increased public awareness of DR and the need for its treatment. As physicians and patients become more alert about the latest technological developments, the key factors that will drive acceptance are improved efficacy, tolerability, and safety profiles, as well as the market penetration of products in the pipeline. Rising general awareness of DR drugs has led to an increase in research funding for clinical and support services. For instance, NDEP is jointly sponsored by the CDC and the NIH. NDEP’s goal is to reduce the illness and deaths caused by diabetes and its complications. Similarly, awareness programs are also organized by the ADA to create awareness, prevent diabetes among at-risk populations, and ensure that all people with diabetes get the best care, treatment, and information about diabetes management.
Covered in this ReportThis report covers the present scenario and the growth prospects of the Global DR market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic injections and drugs used in the treatment of DR.
Global DR Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global DR market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Global DR Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global DR market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one of the main drivers is an increase in the prevalence of diabetes, which has consequently led to a rise in the incidence of DR.
Further, the report states that one of the main challenges is the lack of accurate diagnosis of the disease. Young adults with symptoms of DR are mostly misdiagnosed with DME, macular edema, or glaucoma.
